Intracellular calcium and sodium-lithium countertransport in type 2 diabetic patients with and without albuminuria

Endocrine Journal

Volumn 53, Issue 6, 2006, Pages 773-781

  Völzke, Henry ^a   Gruska, Sybille ^a   Vogelgesang, Dirk ^a   Kerner, Wolfgang ^b   Kraatz, Günter ^a   Rettig, Rainer ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b Center of Cardiology and Diabetes Karlsburg   (Germany)

Author keywords

Albuminuria; Diabetic nephropathy; Intracellular calcium transients; Sodium lithium countertransport

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; CALCIUM; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; LITHIUM; SODIUM; SULFONYLUREA; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; ALBUMINURIA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL IMMORTALIZATION; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; LYMPHOBLAST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SODIUM TRANSPORT;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CALCIUM; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INTRACELLULAR FLUID; ION TRANSPORT; LITHIUM; MALE; MIDDLE AGED; RISK FACTORS; SODIUM;

EID: 33845989130     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K06-065     Document Type: Article

References (46)

1. Levy J, Gavin JR, Sowers JR (1994) Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 96: 260-273.
2. Massry SG, Smogorzewski M (1997) Role of elevated cytosolic calcium in the pathogenesis of complications in diabetes mellitus. Miner Electrolyte Metab 23: 253-260.
3. Song JH, Jung SY, Hong SB, Kim MJ, Suh CK (2003) Effect of high glucose on basal intracellular calcium regulation in rat mesangial cell. Am J Nephrol 23: 343-352.
4. Fujita J, Tsuda K, Seno M, Obayashi H, Fukui I, Seino Y (1996) Elevated erythrocyte sodium-lithium countertransport activity correlates with increased intracellular sodium and free calcium-ion concentration in type 2 diabetes. Diabet Med 13: 53-58.
5. Takaya J, Iwamoto Y, Higashino H, Ishihara R, Kobayashi Y (1997) Increased intracellular calcium and altered phorbol dibutyrate binding to intact platelets in young subjects with insulin-dependent and non-insulin-dependent diabetes mellitus. Metabolism 46: 949-953.
6. Tschöpe D, Rösen P, Gries FA (1991) Increase in the cytosolic concentration of calcium in platelets of diabetics type II. Thromb Res 62: 421-428.
7. Zentay Z, Raguwanshi M, Reddi A, Lasker N, Dasmahapatra A, Aviv A (1995) Cytosolic Ca profile of resting and thrombin-stimulated platelets from black women with NIDDM. J Diabetes Complications 9: 74-80.
8. Alexiewicz JM, Kumar D, Smogorzewski M, Massry SG (1997) Elevated cytosolic calcium and impaired proliferation of B lymphocytes in type II diabetes mellitus. Am J Kidney Dis 30: 98-104.
9. Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG (1995) Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 123: 919-924.
10. Ishii H, Umeda F, Hashimoto T, Nawata H (1990) Changes in phosphoinositide turnover, Ca2+ mobilization, and protein phosphorylation in platelets from NIDDM patients. Diabetes 39: 1561-1568.
11. Duner E, Di Virgilio F, Trevisan R, Cipollina MR, Crepaldi G, Nosadini R (1997) Intracellular free calcium abnormalities in fibroblasts from non-insulin-dependent diabetic patients with and without arterial hypertension. Hypertension 29: 1007-1013.
12. Solini A, Di Virgilio F, Sfriso A, Bruseghin M, Crepaldi G, Nosadini R (1996) Intracellular calcium handling by fibroblasts from non-insulin dependent diabetic patients with and without hypertension and microalbuminuria. Kidney Int 50: 618-626.
13. Trevisan R, Duner E, Cipollina MR, Di Virgilio F, Trevisan M, Nosadini R (1996) Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus. Clin Sci (Colch) 91: 703-710.
14. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G (1992) Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41: 736-741.
15. Schmitz A, Vaeth M (1988) Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 5: 126-134.
16. Mangili R, Zerbini G, Barlassina C, Cusi D, Pozza G (1993) Sodium-lithium countertransport and triglycerides in diabetic nephropathy. Kidney Int 44: 127-133.
17. Besch W, Blücher H, Bettin D, Wolf E, Michaelis D, Kohnert KD (1995) Erythrocyte sodium-lithium countertransport, adenosine triphophatase activity and sodium-potassium fluxes in insulin-dependent diabetes. Int J Clin Lab Res 25: 104-109.
18. Krolewski AS, Canessa M, Warram JH, Laffel LM, Christlieb AR, Knowler WC, Rand LI (1988) Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318: 140-145.
19. Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti G (1988) Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318: 146-150.
20. Walker JD, Tariq T, Viberti G (1990) Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents. Br Med J 301: 635-638.
21. Chiarelli F, Catino M, Tumini S, de Martino M, Mezzetti A, Verrotti A, Vanelli M (1999) Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Care 22: 1158-1164.
22. Monciotti CG, Semplicini A, Morocutti A, Maioli M, Cipollina MR, Barzon I, Palaro C, Brocco E, Trevisan M, Fioretto P, Crepaldi G, Nosadini R (1997) Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM. Diabetologia 40: 654-661.
23. Jensen JS, Mathiesen ER, Norgaard K, Hommel E, Borch-Johnsen K, Funder J, Brahm J, Parving HH, Deckert T (1990) Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia 33: 619-624.
24. Lopes-de-Faria JB, Friedman R, Tariq T, Viberti G (1992) Prevalence of raised sodium-lithium countertransport activity in type 1 diabetic patients. Kidney Int 41: 877-882.
25. Herman WH, Prior DE, Yassine MD, Weder AB (1993) Nephropathy in NIDDM is associated with cellular markers for hypertension. Diabetes Care 16: 815-818.
26. Fujita J, Tsuda K, Seno M, Obayashi H, Fukui I, Seino Y (1994) Erythrocyte sodium-lithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy in NIDDM. Diabetes Care 17: 977-982.
27. Dowd A, Thomas TH, Taylor R, Wilkinson R (1994) Erythrocyte sodium-lithium countertransport activity is related to membrane fluidity in IDDM patients. Diabetologia 37: 394-400.
28. van Dijk DJ, Erman A, Panski R, Lilos P, Kalter-Leibovici O, Karp M, Boner G (1996) Sodium-lithium countertransport: a predictor of diabetic nephropathy in Jewish insulin-dependent diabetes mellitus patients of different ethnic origin? Isr J Med Sci 32: 105-111.
29. Vervoort G, Elving LD, Wetzels JF, Lutterman JA, Smits P, De Pont JJ, Berden JH (2002) Sodium-lithium countertransport is increased in normoalbuminuric type 1 diabetes but is not related to other risk factors for microangiopathy. Eur J Clin Invest 32: 93-99.
30. Elving LD, Wetzels JF, De Pont JJ, Berden JH (1992) Is increased erythrocyte sodium-lithium countertransport a useful marker for diabetic nephropathy? Kidney Int 41: 862-871.
31. Rutherford PA, Thomas TH, Carr SJ, Taylor R, Wilkinson R (1992) Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy. Clin Sci (Colch) 82: 301-307.
32. Crompton CH, Balfe JW, Balfe JA, Chatzilias A, Daneman D (1994) Sodium-lithium transport in adolescents with IDDM. Relationship to incipient nephropathy and glycemic control. Diabetes Care 17: 704-710.
33. Senda T, Serizawa N, Negishi K, Katayama S (1996) Elevated erythrocyte sodium-lithium countertransport in hypertensive patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 31: 37-44.
34. Pinkney JH, Foyle WJ, Denver AE, Mohamed-Ali V, McKinlay S, Yudkin JS (1995) The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM. Diabetologia 38: 356-362.
35. Rutherford PA, Thomas TH, Taylor R, Wilkinson R (1994) Nephropathy and changes in sodium-lithium countertransport kinetics in type 2 (non-insulin-dependent) diabetes mellitus. J Hum Hypertens 8: 29-35.
36. Giordano M, Castellino P, Solini A, Canessa ML, DeFronzo RA (1997) Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment. Metabolism 46: 1316-1323.
37. Foyle WJ, Fernandez M, Denver E, Sampson MJ, Pinkney J, Yudkin JS (1996) Cellular sodium membrane transport and cardiovascular risk factors in non-insulin-dependent diabetes mellitus. Metabolism 45: 961-965.
38. Gall MA, Rossing P, Jensen JS, Funder J, Parving HH (1991) Red cell Na+/Li+ countertransport in non-insulin-dependent diabetics with diabetic nephropathy. Kidney Int 39: 135-140.
39. Van Norren K, Thien T, Berden JH, Elving LD, De Pont JJ (1998) Relevance of erythrocyte Na+/Li+ countertransport measurement in essential hypertension, hyperlipidaemia and diabetic nephropathy: a critical review. Eur J Clin Invest 28: 339-352.
40. Wirta OR, Pasternack AI, Mustonen JT, Koivula TA, Harmoinen A (1996) Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients. Nephrol Dial Transplant 11: 449-456.
41. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop L (2001) The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 44: 1148-1154.
42. Rosskopf D, Fromter E, Siffert W (1993) Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. A cell culture model for human hypertension. J Clin Invest 92: 2553-2559.
43. Gruska S, Ihrke R, Stolper S, Kraatz G, Siffert W (1997) Prevalence of increased intracellular signal transduction in immortalized lymphoblasts from patients with essential hypertension and normotensive subjects. J Hypertens 15: 29-33.
44. Besch W, Schläger D, Brahm J, Kohnert KD (1995) Validation of red cell sodium-lithium countertransport measurement - Influence of different loading conditions. Eur J Clin Chem Clin Biochem 33: 715-719.
45. Hurst RD, Stevanovic ZS, Munk S, Derylo B, Zhou X, Meer J, Silverberg M, Whiteside CI (1995) Glomerular mesangial cell altered contractility in high glucose is Ca2+ independent. Diabetes 44: 759-766.
46. Coonrod BA, Ellis D, Becker DJ, Dorman JS, Drash AL, Kuller LH, Orchard TJ (1989) Assessment of AlbuSure and its usefulness in identifying IDDM subjects at increased risk for developing clinical diabetic nephropathy. Diabetes Care 12: 389-393.